But while the U.S. Food and Drug Administration has approved more than two dozen drugs targeting a range
of male
sexual matters, pharma has turned a cold shoulder to female
dysfunction, despite the
prevalence of conditions like hypoactive
sexual desire disorder, a chronic disinterest in sex estimated to affect 8 to 14 percent
of American women ages 20 to 49.
Felitti and colleagues1 first described ACEs and defined it as exposure to psychological, physical or
sexual abuse, and household
dysfunction including substance abuse (problem drinking / alcoholic and / or street drugs), mental illness, a mother treated violently and criminal behaviour in the household.1 Along with the initial ACE study, other studies have characterised ACEs as neglect, parental separation, loss
of family members or friends, long - term financial adversity and witness to violence.2 3 From the original cohort
of 9508 American adults, more than half
of respondents (52 %) experienced at least one adverse childhood event.1 Since the original cohort, ACE exposures have been investigated globally revealing comparable
prevalence to the original cohort.4 5 More recently in 2014, a survey
of 4000 American children found that 60.8 %
of children had at least one form
of direct experience
of violence, crime or abuse.6 The ACE study precipitated interest in the health conditions
of adults maltreated as children as it revealed links to chronic diseases such as obesity, autoimmune diseases, heart, lung and liver diseases, and cancer in adulthood.1 Since then, further evidence has revealed relationships between ACEs and physical and mental health outcomes, such as increased risk
of substance abuse, suicide and premature mortality.4 7
Sexuality Healing and the Rights
of Patients and Clients: AASECT recognizes the
prevalence of sexual practices that are unhealthy, and unhappy, and acknowledges that many people struggle with
sexual distress, disorder, and
dysfunction.